Related Experiment Video
Updated: Mar 31, 2026

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Soy protein isolate does not affect ellagitannin bioavailability and urolithin formation when mixed with pomegranate
Jieping Yang1, Rupo Lee1, Susanne M Henning1
1Center for Human Nutrition, David Geffen School of Medicine, Department of Microbiology, Immunology and Molecular Genetics, United States.
Abstract:
We investigated the effect of mixing soy protein isolate and pomegranate juice (PJ) on the bioavailability and metabolism of ellagitannins (ETs) in healthy volunteers. Eighteen healthy volunteers consumed PJ alone or PJ premixed with soy protein isolate (PJSP). The concentration of plasma ellagic acid (EA) and urine urolithins was measured. There was no significant difference in plasma EA over a 6-h period between the two interventions. While the maximum concentration of plasma EA after PJSP consumption was slightly but significantly lower than after PJ consumption, EA remained in the plasma longer with an elimination half-life t1/2E at 1.36±0.59 versus 1.06±0.47h for PJSP and PJ consumption, respectively. Urinary urolithin A, B and C was not significantly different between the two interventions. In conclusion, premixing soy protein isolate and PJ did not affect the bioavailability or the metabolism of pomegranate ETs in healthy volunteers.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Urinary Tract Calculi IV: Nutrition Therapy and Prevention

